University research records
Volgograd State Medical University
5 imported, source-linked research records. All imported publication dates.
All imported publication dates
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Volgograd State Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial
April 6, 2024 · 103 citations · Open access
Open original record →Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
November 9, 2021 · 53 citations · Open access
Open original record →Sodium–Glucose Co-Transporter 2 Inhibitors in Heart Failure: Beyond Glycaemic Control. A Position Paper of the Heart Failure Association of the European Society of Cardiology
July 3, 2020 · 131 citations · Open access
Open original record →European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients with Heart Failure
December 9, 2019 · 178 citations · Open access
Open original record →Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
March 8, 2018 · 708 citations · Open access
Open original record →